LDN for Weight Loss: Benefits, Safety, and Side Effects

What is Low Dose Naltrexone?

Naltrexone is an FDA-approved medication used to treat opioid and alcohol use disorders. At standard doses (typically 50 mg), it works by fully blocking opioid receptors in the brain.

In contrast, low-dose naltrexone (LDN) refers to naltrexone administered at doses much lower than those used in standard therapy, typically between 1 mg and 6 mg. At these lower doses, naltrexone does not produce sustained opioid receptor blockade; instead, it is thought to cause a brief, partial, and transient blockade, which may lead to downstream effects on endorphin production and immune signaling.

So, where does weight loss come into the picture?

With nearly 70% of adults in the U.S. classified as overweight or obese, for many, losing weight and keeping it off can feel like an uphill battle. Even with the best intentions, conventional approaches such as calorie restriction and exercise don’t always yield lasting results.

The truth is that weight management isn’t simply about willpower. Hormones, insulin sensitivity, inflammation, and even emotional eating patterns all play a part in how the body responds to lifestyle changes. This is why many people are beginning to look beyond traditional methods and consider medical interventions that target these underlying factors.

Although it’s not FDA-approved for this purpose, some clinicians have explored low-dose naltrexone (LDN) as part of broader, individualized care approaches, despite limited evidence specific to weight loss.

‍

{{primary-cta}}

‍

Low Dose Naltrexone Benefits for Weight Loss

LDN doesn’t suppress appetite the way some prescription drugs do, and it won’t deliver rapid results on its own. But for some people, it has been explored by clinicians as part of broader care approaches, though it has not been shown to directly support weight loss.

‍

Cravings and Appetite

Some individuals anecdotally report changes in eating behaviors while taking LDN, but these reports are not supported by consistent clinical evidence.

Ultimately, research on LDN for appetite or craving regulation is still limited, and responses can vary. 

‍

Insulin Sensitivity and Inflammation

Insulin resistance is a common roadblock for many people trying to lose weight. When your cells don’t respond efficiently to insulin, your body may be more likely to store fat. Some preclinical and limited clinical research has examined LDN’s effects on inflammation and metabolic signaling, but its impact on insulin sensitivity in humans is not well established.

In limited studies, LDN has also shown anti-inflammatory effects, which may be relevant to ongoing research on metabolic and inflammatory pathways. Yet, more research is needed, and individual responses can vary.

‍

Possible Support for Mood and Emotional Eating Patterns

The emotional side of eating can be a major mental hurdle for some individuals to overcome during their weight loss journey. So, where might LDN come into play here?

LDN is thought to interact with endorphin pathways, which are involved in mood and stress regulation. In fact, some individuals report changes in mood, sleep, or overall well-being while taking LDN, though research in this area is limited.

Ultimately, any observed changes in eating behaviors or emotional patterns may vary significantly from person to person. LDN isn’t FDA-approved for mood, sleep, or weight-related conditions, and further clinical research is needed to better understand these effects.

‍

What Does the Research Say About LDN for Weight Loss?

Research on LDN for weight loss remains limited. Most of the available evidence comes from small studies, case reports, or research focused on related conditions.

With that said, some related research includes:

• One small clinical study in women with PCOS used naltrexone 50 mg per day (a standard dose, not LDN) and reported decreases in BMI, reductions in androgen-related hormones, and improved fasting glucose-to-insulin ratio in that specific study population; these findings do not apply to low-dose naltrexone.
• By contrast, the combination of naltrexone and bupropion (Contrave®) has been studied in larger trials. In the COR-II Phase 3 study, 50.5% of participants achieved at least 5% weight loss at 56 weeks, compared with 17.1% with placebo.

For LDN on its own, evidence remains largely anecdotal or based on clinical observations, and weight-related outcomes have not been consistently demonstrated in controlled trials.

‍

{{primary-cta}}

‍

Who Might Be a Good Candidate for LDN?

LDN isn’t for everyone, and results can vary widely from person to person. However, some clinicians consider LDN in specific contexts, despite limited evidence identifying clear responder groups.

• Individuals with PCOS or insulin resistance: Hormonal imbalances and insulin resistance can complicate weight management, and some providers explore LDN as part of an individualized approach.
• Those with autoimmune or thyroid conditions: LDN has been studied for its potential immune-modulating effects, and addressing underlying thyroid or autoimmune factors may indirectly influence metabolic health.
• Individuals who struggle with emotional eating patterns: Because LDN is thought to interact with endorphin pathways, some individuals report changes in cravings or appetite awareness, though evidence is limited.
• Individuals who have plateaued despite lifestyle changes: When consistent diet and activity efforts stall, LDN may be considered to address possible biological factors alongside healthy habits.

These considerations reflect clinical exploration, not established indications, and LDN hasn’t been proven effective for weight loss in these groups.

‍

Safety and Medical Considerations

Many people report tolerating LDN well, and side effects often tend to be mild and temporary. The most frequently reported include:

• Vivid dreams or disrupted sleep
• Headaches
• Nausea
• Mild fatigue or dizziness

Many of these effects improve within the first few weeks. Taking LDN at a different time of day or with food can also sometimes help manage symptoms, such as nausea or sleep disturbances.

On the flip side, you should not take LDN if you:

• Currently use opioid medications (including methadone or buprenorphine)
• Are in acute withdrawal from opioids or alcohol
• Are pregnant or breastfeeding
• Have significant liver disease
• Have surgery scheduled that may require opioid pain management

If you take thyroid medication, your provider may want to monitor your levels more closely after starting LDN.

‍

Final Thoughts

Research is still lagging behind clinical interest, and more studies are needed to fully understand who may benefit from LDN and why. In the meantime, the best path forward is discussing your specific options with a licensed healthcare provider. They can determine what makes the most sense for you and your health journey.